PARG and pancreatic neoplasm: Furthermore, PARG deficient −/− embryonic stem cells and PARG depleted pancreatic cancer cells exhibited S-phase arrest and increased DNA damage when treated with the alkylating agent MMS (Shirai et al., 2013b).